Publications by authors named "Trisha Rogers"

Claim this Profile
I
Implications of high prevalence of recreational drug use among cases of infectious syphilis: insights from state-wide surveillance data, South Australia, July 2022 - September 2023.
Jana Sisnowski, Trisha Rogers, Jaime Pearson, Sarah Del Fante, Jamie Hermanson

Commun Dis Intell (2018)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on chemokine and proinflammatory cytokine expression in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.
Hui Wang, Trisha J Rogers, James C Paton, Adrienne W Paton

Infect Immun· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The B subunit of an AB5 toxin produced by Salmonella enterica serovar Typhi up-regulates chemokines, cytokines, and adhesion molecules in human macrophage, colonic epithelial, and brain microvascular endothelial cell lines.
Hui Wang, James C Paton, Brock P Herdman, Trisha J Rogers, Travis Beddoe

Infect Immun· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of lipid rafts and flagellin in invasion of colonic epithelial cells by Shiga-toxigenic Escherichia coli O113:H21.
Trisha J Rogers, Cheleste M Thorpe, Adrienne W Paton, James C Paton

Infect Immun· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.
Dakshina M Jandhyala, Trisha J Rogers, Anne Kane, Adrienne W Paton, James C Paton

Infect Immun· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic strategies for Shiga toxin-producing Escherichia coli infections.
Trisha J Rogers, James C Paton

Expert Rev Anti Infect Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model.
Lorwai Tan, Trisha J Rogers, Nick Hatzirodos, Leonie M Baker, Enghooi Ooi

Am J Rhinol Allergy· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
Carla Calderon Toledo, Trisha Jayne Rogers, Majlis Svensson, Ramesh Tati, Hans Fischer

Am J Pathol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling the passage of light through metal microchannels by nanocoatings of phospholipids.
Shannon M Teeters-Kennedy, Kenneth R Rodriguez, Trisha M Rogers, Keith A Zomchek, Shaun M Williams

J Phys Chem B· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21.
Trisha J Rogers, James C Paton, Hui Wang, Ursula M Talbot, Adrienne W Paton

Infect Immun· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli.
Trisha J Rogers, Adrienne W Paton, Shaun R McColl, James C Paton

Infect Immun· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis